Roivant Sciences (ROIV) Revenue (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Revenue data on file, last reported at $5.7 million in Q4 2025.

• Quarterly Revenue fell 73.28% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.0 million (down 46.28% YoY) and the FY2026 annual result came in at $8.3 million, down 71.57% from the prior year.
• Revenue climbed to $5.7 million in Q4 2025, from $1.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $46.1 million in Q4 2021 to a low of $1.6 million in Q3 2025.
• A 5-year average of $14.1 million and a median of $8.0 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2021 — Revenue surged 957.22% — and 2025, when it slumped 73.28%.
• Tracing ROIV's Revenue over 5 years: stood at $46.1 million in 2021, then declined by 26.4% to $33.9 million in 2022, then sank by 30.12% to $23.7 million in 2023, then slipped by 9.33% to $21.5 million in 2024, then tumbled by 73.28% to $5.7 million in 2025.
• The last three Revenue figures came in at $5.7 million (Q4 2025), $1.6 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.